Phytochemical Screening and Acute Oral Toxicity Studies of Seeds of Hyptis Suaveolens and Fruits of Coccinia Grandis.
Pharmaceutical Science-Pharmacology
DOI:
https://doi.org/10.22376/ijlpr.2023.13.5.P6-P13Keywords:
OECD, GHS classification system (Globally Harmonised System), Hyptis suaveolens, Coccinia grandis, Phytochemical, acute toxicity.Abstract
Hyptis suaveolens, a member of the Lamiaceae family, is traditionally used as a carminative and an expectorant. It is also found to haveanti-inflammatory, antimicrobial, and anti-cancer potential. Coccinia grandis, a member of the Cucurbitaceae family, is found to be anti-helminthic,antioxidant, anti-ulcer, anti-malarial, anti-inflammatory, antipyretic, analgesic, antifungal, antitussive and hypoglycemic in different animal models.The objective of the present study is intended to focus on the phytochemical evaluation of Hyptis suaveolens seeds and Coccinia grandis fruits andto study their toxic effects by acute oral toxicity study and establish the safety category of these extracts as per organization for economiccooperation and development (OECD-TG-423) guidelines and GHS classification system. Hyptis suaveolens seeds, and Coccinia grandis fruits werecollected, and the extraction was made and stored for phytochemical analysis. The extract was tested for phytochemical constituents like alkaloids,phenol, flavonoids, carbohydrates, triterpenes, sterols, saponins, and tannins. In an acute oral toxicity study, the hydroalcoholic extracts of bothplants were administered orally at a dose of 2000mg/Kg b.w. to the three rats in each group in Step I of the individual group. They were observedfor 48 hrs and followed for 14 days (step II). They were examined for sensory, physiological, and behavioral parameters and signs of toxicity andmortality. The phytochemical study revealed the presence of many pharmacologically active constituents, and the acute oral toxicity study showedno changes in physical, sensory, physiological, or behavioral parameters, with all animals remaining healthy and active. There were no signs ofmortality or moribund status in both step I and II. The results indicate that the hydroalcoholic extracts of Hyptis suaveolens seeds and Cocciniagrandis fruits fall under category '5' or 'unclassified' of the GHS system, allowing them to be used safely in pharmaceutical formulations fortherapeutic use.
References
Kelly K. History of medicine. New York: Facts on file; 2009. p. 29-50.
WHO (World Health Organization). The world's traditional medicines situation. In: Traditional medicines: global situation, issues, and challenges. Vol. 3. Geneva; 2011. p. 1-14.
Mir AH, Sexena M, Malla MY. An acute oral toxicity study of methanolic extract from Tridex procumbens in Sprague Dawley’s rats as per OECD Guidelines 423. Asian J Plant Sci Res. 2013;3:16-20.
Aneela S, De S, Kanthal LK, Choudhury NS, Das BL, Sagar KV. Acute oral toxicity studies of Pongamia pinnata and Annona squamosa on albino Wistar rats. Int J Res Pharm Chem. 2011;1(4):820-4.
Parasuraman S. Toxicological screening. J Pharmacol Pharmacother. 2011;2(2):74-9. doi: 10.4103/0976-500X.81895, PMID 21772764.
Yoganarasimhan SN. Hyptis suaveolens. In: Srinivasan V, Kosal Ram N editors. Medicinal plants of India. Vol. II. Bangalore: Cyber Media; 2000p. p. 282.
Mishra P, Sohrab S, Mishra SK. A review of the phytochemical and pharmacological properties of Hyptis suaveolens (L.) Poit. Futur J Pharm Sci. 2021;7(1):65. doi 10.1186/s43094-021-00219-1, PMID 33728353.
Shenoy C, Patil MB, Kumar R. Wound healing activity of Hyptis suaveolens (L.) Poit. (Lamiaceae). Int J Pharm Tech Res. 2009;1(3):737-44.
Gavani U, Paarakh PM. Antioxidant Activity of Hyptis suaveolens Poit. Int J Pharmacol. 2008;4(3):227-9. doi: 10.3923/ijp.2008.227.229.
Kumar M, Alok S, Chanchal DK, Bijauliya RK, Yadav RD, Sabharwal M. An updated pharmacological activity of Coccinia indica (wight & arn.). Int J Pharm Sci Res. 2018;9:456-65.
Pekamwar SS, Kalyankar TM, Kokate SS. Pharmacological activities of Coccinia grandis [review]. J Appl Pharm Sci. 2013;3(05):114-19.
Iqbal E, Salim KA, Lim LBL. Phytochemical screening, total phenolics, and antioxidant activities of bark and leaf extracts of Goniothalamus velutinus (Airy Shaw) from Brunei Darussalam. J King Saud Univ Sci. 2015;27(3):224-32. doi: 10.1016/j.jksus.2015.02.003.
Singh JB, Tailang M. Phytochemistry and pharmacological profile of traditionally used medicinal plant Argyreia speciosa (Linn.f.). J Drug Deliv Ther. 2018;8(5):41-6.
Nigussie D, Davey G, Legesse BA, Fekadu A, Makonnen E. Antibacterial activity of methanol extracts of the leaves of three medicinal plants against selected bacteria isolated from wounds of lymphoedema patients. BMC Complement Med Ther. 2021;21(1):2. doi: 10.1186/s12906-020-03183-0, PMID 33390165.
OECD. Guideline for testing of chemicals. Vol. 423 Acute oral toxicity – acute toxic class method. Organization for Economic Co-operation and Development; 2001.
Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol. 2014;4(177):177. doi: 10.3389/fphar.2013.00177, PMID 24454289.
Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol. 2014;4(177):177. doi: 10.3389/fphar.2013.00177, PMID 24454289.
Ibrahim MB, Sowemimo AA, Sofidiya MO, Badmos KB, Fageyinbo MS, Abdulkareem FB et al. Sub-acute and chronic toxicity profiles of Markhamia tomentosa ethanolic leaf extract in rats. J Ethnopharmacol. 2016;193:68-75. doi 10.1016/j.jep.2016.07.036, PMID 27426507.
Agarwal K, Varma R. Antioxidant activity and Phytochemical analysis of Hyptis suaveolens (L.) Poit. J Adv Pharm Edu Res. 2013;3(4):541-9.
Nayak S, Kar DM, Nayak S. Evaluation of antidiabetic and antioxidant activity of aerial parts of Hyptis suaveolens Poit Afr J Pharm Pharmacol. 2013;7(1):1-7. doi: 10.5897/AJPP12.350.
Jesus, Neyres & Falcão, H.S. & Lima, Gedson & Filho, M.R.D. & Sales, Igor & Gomes, Isis & Santos, S & Tavares, Josean & Barbosa Filho, Jose & Batista, Leônia. Hyptis suaveolens (L.) Poit (Lamiaceae), a medicinal plant that protects the stomach against several gastric ulcer models—Journal of Ethnopharmacology 2013;150. 10.1016/j.jep.2013.10.010.
Aggarwal AS, Suralkar UR, Chaudhari SG, Deshpande SV, Garud AA, Talele SG. Analgesic and antipyretic activity of methanolic extract of Coccinia grandis L. Leaves in experimental animals. Res J Pharm Biol Chem Sci. 2011;2:175-82.
Bhattacharya B, Lalee A, Mal DK, Samanta A. In vivo and in vitro anticancer activity of Coccinia grandis (L.) Voigt (Family: Cucurbitaceae) on Swiss albino mice. J Pharm Res. 2011;4:567-69.
Mohammed SI, Vishwakarma KS, Maheshwari VL. Evaluation of the larvicidal activity of essential oil from leaves of Coccinia grandis against three mosquito species. J Arthropod Borne Dis. 2017;11(2):226-35. PMID 29062847.
Taur DJ, Patil RY. Mast cell stabilizing, the anti anaphylactic and antihistaminic activity of Coccinia grandis fruits in asthma. Chin J Nat Med. 2011;9:359-62.
Kumar VK, Lalitha K. Acute oral toxicity studies of Anacyclus pyrethrum dc root in albino rats. Int J Pharm Pharm Sci. 2013;5(4):675-8.
Greaves P. Histopathology of preclinical toxicity studies: interpretation and relevance in drug safety evaluation. Academic Press; 2011.
El Hilaly J, Israili ZH, Lyoussi B. Acute and chronic toxicological studies of Ajuga iva in experimental animals. J Ethnopharmacol. 2004;91(1):43-50. doi 10.1016/j.jep.2003.11.009, PMID 15036466.
M R, Oa A, Tm E, Aa A. Effect of prolonged vigabatrin treatment on hematological and biochemical parameters in plasma, liver, and kidney of Swiss albino mice. Sci Pharm. 2002;70(2):135-45. doi: 10.3797/sci-pharm.aut-02-16.
Teo S, Stirling D, Thomas S, Hoberman A, Kiorpes A, Khetani V. A 90-day oral gavage toxicity study of D-methylphenidate and D, L-methylphenidate in Sprague-Dawley rats. Toxicology. 2002;179(3):183-96. doi: 10.1016/s0300-483x(02)00338-4, PMID 12270592.
Klaassen CD. Principles of toxicology. In: Casarett and Doull's Toxicology: the basic science of Poisons. 5th ed. New York: McGraw-Hill; 2001. p. 13.
Published
How to Cite
Issue
Section
Copyright (c) 2023 Jagannath Narumalla, Dr.D. Sheela, Dr. Rohit Dixit
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.